4
Changes in Ownership
BridgeBio Pharma, Inc. Filed Acc 0001209191-23-048595
Director sold 2,500 shares at $30.00 ($75,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scott Randal W. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-05 | Sale : show line 1 in the form 10b5-1 | −2,500 | $30.00 | $75,000 | 13,500 | I |
| Open-market sales · 2,500 sh · avg $30.00 · $75,000 | ||||||
Loading xslF345X05/doc4.xml…